Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

Establishing a multidisciplinary taskforce to improve anticoagulation safety at a large health system.

Attia E, Fuentes A, Vassallo M, et al. Establishing a multidisciplinary taskforce to improve anticoagulation safety at a large health system. Am J Health Syst Pharm. 2022;79(4):297-305. doi:10.1093/ajhp/zxab411.

Save
Print
December 12, 2021
Attia E, Fuentes A, Vassallo M, et al. Am J Health Syst Pharm. 2022;79(4):297-305.
View more articles from the same authors.

Anti-coagulants are classified as high-risk medications due to their potential to cause serious patient harm if not administered correctly. This hospital created a multidisciplinary anticoagulant safety taskforce to reduce errors and improve patient safety. The article describes the implementation process, including the use of the 2017 Institute for Safe Medication Practices (ISMP) Medication Safety Self-Assessment for Antithrombotic Therapy tool.

Save
Print
Cite
Citation

Attia E, Fuentes A, Vassallo M, et al. Establishing a multidisciplinary taskforce to improve anticoagulation safety at a large health system. Am J Health Syst Pharm. 2022;79(4):297-305. doi:10.1093/ajhp/zxab411.